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ABSTRACT 
 
 
 
 
In recent years, there has been an increase in public concern on the safety and 
efficacy of cosmetic ingredients. Recently, the potential Labisia pumila (L. pumila) 
for cosmetic application was expanded as a skin moisturizer product. However, the 
general toxicity effect of L. pumila on skin is not well understood. Hence, the 
objective of this study was to carry out the safety assessment of L. pumila for 
cosmeceutical applications. This research encompassed cytotoxicity study, allergic 
dermatitis assessment, genotoxicity study, ocular irritancy and in vivo toxicological 
study. Based on the results, L. pumila was relatively non-cytotoxic up to 0.001 
mg/mL.  Penetration and absorption analyses revealed that overall recovery was in 
range of 100±15% and were considered acceptable with each of 500 mg/mL and 
1000 mg/mL of extracts, respectively. The L. pumila extract did not cause mutagenic 
effects on Salmonella thyphimurium in the presence or absence of metabolic 
activation. Allergic contact dermatitis assessment through in vitro dermal irritation 
study showed the mean cell viability was found to be 91.5% with a standard 
deviation of ± 3.17%.  However, sensitization analysis indicated that the extract is a 
sensitizer due to the average depletion of both peptides at 17.75%, more than 6.37% 
with low reactivity. The Bovine Corneal Opacity and Permeability (BCOP) 
examination indicated that non-ocular irritation occurred. After a single dose of 
dermal application in acute dermal toxicity study, estimation of lethal dose was 2000 
mg/kg.  The repeated dose for 28-days dermal toxicity study also indicated Non-
Observed Adverse Effect Level (NOAEL) was noted up to 1000 mg/kg. From all of 
the analyses conducted, this pre-clinical safety assessment suggested that the L. 
pumila water extract is safe for present practices with the appropriate concentration 
for cosmetic formulation. 
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ABSTRAK 
 
 
 
 
Kesedaran masyarakat hari ini kian meningkat terhadap keselamatan serta 
keberkesanan bahan-bahan kosmetik. Kebelakangan ini, potensi Labisia pumila       
(L. pumila) diperluas dalam applikasi kosmetik seperti produk krim pelembab wajah.  
Walau bagaimanapun, kesan toksik kepada kulit secara amnya masih belum jelas.  
Oleh itu, kajian ini bertujuan menilai tahap keselamatan L. pumila bagi applikasi 
kosmetik. Kajian ini melibatkan ujian kesitotoksikan, penilaian alahan dermatitis, 
keradangan okular, ujian kegenotoksikan dan kajian toksikologi in vivo. Hasil kajian 
menunjukkan 0.001 mg/mL ekstrak adalah tidak sitotoksik secara relatif.  Analisis 
ujian penembusan dan penyerapan mencatatkan nilai 100±15% kadar pemulihan bagi 
setiap 500 mg/mL dan 1000 mg/mL ekstrak.  Ekstrak  L. pumila tidak menyebabkan 
kesan mutagen kepada Salmonella thyphimurium dengan kehadiran atau 
ketidakhadiran pengaktifan metabolik.  Penilaian alahan dermatitis melalui ujian 
kerengsaan kulit secara in vitro menunjukkan daya maju sel pada tahap 91.5% 
dengan sisihan piawai ± 3.17%. Walau bagaimanapun, analisis pemekaan 
mencatatkan purata nilai kedua-dua peptid 17.75% melebihi nilai piawaian sebanyak 
6.37% dengan keaktifan yang rendah. Pemeriksaan Kelegapan dan Kebolehtelapan 
Kornea Bovin (BCOP) menunjukkan tiada alahan okular berlaku. Selepas applikasi 
dos tunggal ujian ketoksikan dermis akut, anggaran dos maut adalah 2000 mg/kg.   
Ujian applikasi berulang untuk 28 hari ujian ketoksikan dermis juga menunjukkan 
aras Kesan Buruk yang Tidak Diperhatikan (NOAEL) sehingga 1000 mg/kg.  
Daripada analisis yang dijalankan, penilaian keselamatan melalui kajian pre-klinikal 
ini menjangkakan bahawa ekstrak L. pumila adalah selamat untuk penggunaan buat 
masa ini dengan kepekatan yang sesuai untuk formulasi kosmetik. 
!
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background of the Study 
 
 
A large number of cosmetic consumers recently had shown progressive 
interest in the prevention of aging skin and maintaining their youthful appearance by 
using product from natural ingredients. Generally, the safety of the cosmetic is based 
on the safety of it active ingredient (Darr et al, 1996).  This statement was in 
accordance with European cosmetic legislation and Scientific Committee of 
Consumer Product (SCCP), which prohibits final products containing hazardous 
ingredient that may affect human health (SCCP, 2006).  
 
 
The growth of natural cosmetic industry nowadays is increasing 
tremendously with cosmetic consumers awareness.  The term ‘Natural Product’ 
synonymously interpreted as ‘safe’ product due to its organic origin, even the fact 
that natural ingredient may have a greater variability of content compared to 
synthetically produced product.  It must be noted that natural ingredients may also 
have a potential of batch to batch inconsistency and prone to contamination due to 
the harvesting process (Larry, 2001).  It was also reported that many poisonous 
alkaloid came from the natural products and numerous products are lacking the 
 2 
acceptable quality and safety standards.  The issue was due to the product developer 
not following a scientifically bases to assess any product benefits and safety 
guidelines.  
 
 
There is limited number of research journals in the area of evaluation in mode 
of action, efficacy, physiological and metabolic changes and also toxicity levels of 
the natural extract compared with amount of commercial products available in the 
market (Melissa et al, 2008; Ezumi et al: 2006).  None of the toxicological profile 
was provided; a probability deleterious effect on human health was not evaluated. 
The safety assessment of natural ingredient is important in order to approach the 
general acceptance of basic systemic margin safety and attempt to propose any 
potential health risk due to application or exposure such as adverse dermal effect. 
The adverse dermal effect including dermatitis contact irritation, immediate or delay 
allergic reaction and also skin sensitization (Bakalli et al., 2008) may develop upon 
exposure.  With this respect, the safety issue of the natural ingredient must take into 
account (Eric et al., 2011). 
 
 
Kligman (1993) in his dermatologist guidelines, also indicates the safety of 
naturals ingredients including the potential of the active ingredient penetrating the 
various layers of the dermal skin and can delivered in sufficient concentration to the 
intended target consistently over time application.  He also mentioned the important 
of specifying the bioactive compound mechanism of action in the target cells or skin.  
Such claims should be initiated together with any publication regarding the plant 
biological references, pre-review, pre-clinical trial or significant clinical trial to 
substantiate the efficacy claims. 
 
 
The natural ingredients that were used in cosmetic product usually came from 
various plant extracts of wild herbal roots, leaves, or even bulbs.  These natural 
ingredients were used more than a decade as traditional remedies among the local 
people either to treat internal diseases or topical application.  One of the well-known 
 3 
herbal among Malaysian women is Labisia pumila that is locally known as ‘Kacip 
Fatimah’. 
 
 
 The L. pumila has been used traditionally to address for post-partum 
conditions (Zakaria and Muhammad, 1994; Ayida et al, 2008; Singh et al, 2009).  It 
was also used widely for post-partum tonic, firm abdominal muscle, improve body 
strength, and regulate the menses (Shahrim, 2006, Yan et al., 2012).  A recent study 
also revealed that the extract benefited the skin by topical application.  The               
L. pumila extract was also reported to promote cells regeneration and exhibits      
antiphoto-aging properties (Choi et al, 2010).  Moreover, its also reported to inhibit 
microbial activity (Karimi et al., 2011), anti-stress (Kaur et al., 2010) and potentially 
used for polycystic Ovarian Syndrome (PCOS) treatment (Manneras et al, 2010).  
 
 
 Currently, the commercially prepared L. pumila extract is widely available in 
the market either in capsule, liquid or powder form as herbal supplement.  The 
benefits of the extract also had been added into flavored drive such as pre-mixed 
tea/coffee as daily beverages.  Besides that, its also found been added as active 
ingredient in cosmetic product such as daily moisturizer for skin improvement due to 
flavonoids, anti-oxidant properties present inside the extract.  The antioxidant 
activity of the aqueous L. pumila extract has been reported to provide significant 
protection to human dermal fibroblasts, from cell damage caused by UV irradiation 
(Choi et al., 2010).  However, the safety issues of the extract itself on dermal 
application were not well reported. 
 
Based on these considerations, the final research finding will give a better 
understanding of its effect on human skin when applied topically. Hence, this 
evaluation of the L. pumila extract towards hazard dermatological potential in 
cosmetic application will contribute to the cosmetic industry by giving the safety 
limit of the extract for cosmetic formulation.  
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1.2 Problem Statement 
 
 
 Consequently, according to previous studies it can be suggested that the        
L. pumila extract offers great potential for the prevention of skin aging and also 
benefited to improve the skin health based on its physiochemical and biological 
properties.  
 
 
 However, the assessment on dermatological effect on skin is not well 
reported. This evaluation is important for margin safety of cosmetic formulation 
especially under actual condition of use.  The lack of information may develop 
dermal adverse effect that can cause various skin diseases such as contact dermatitis, 
severe irritation and chronic allergic reaction. 
 
 
 Therefore, this study provides a profile of the L. pumila extract to address 
safety issues for cosmetic formulation and may help in the development of new 
cosmetic product.  It also gives the best correlation between risk and the benefit for 
developing a safe cosmetic product in the market. 
 
 
 
 
1.3 Objective of The Study 
 
 
 The main objective of this research is to establish the dermatoxicological 
profile of L. pumila extract for cosmetic formulation. 
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1.4 Scopes of The Study 
 
 
 Following scopes of research were applied in order to fulfill the objectives:   
 
1.4.1 To determine cytotoxicity effect of L. pumila extract for                  
pre-assessment toxicological studies using direct cells contact method. 
1.4.2 To investigate the penetration and absorption potential of L. pumila 
extract on Reconstructed Epidermis Human Skin (Epiderm TM). 
1.4.3 To demonstrated the effect of L. pumila extract on genotoxicity and 
mutagenicity via AMES test on Salmonella thypimurium. 
1.4.4 To investigate the allergic contact dermatitis through sensitivity tests 
consisting of in vitro dermal irritation and sensitization test.  
1.4.5 To assess ocular opacity and permeability by BCOP analysis for eye 
irritation evaluation. 
1.4.6 To investigate NOEL and NOAEL of L. pumila on Sprague Dawley 
rats using acute dermal toxicity test and dermal repeated dose 28-days 
toxicity study. 
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